@article{buatois:hal-02474041,
TITLE = {Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia},
AUTHOR = {Buatois, Vanessa and Johnson, Zo{\"e} and Salgado-Pires, Susana and Papaioannou, Anne and Hatterer, Eric and Chauchet, Xavier and Richard, Fran{\c c}oise and Barba, Leticia and Daubeuf, Bruno and Cons, Laura and Broyer, Lucile and d'Asaro, Matilde and Matthes, Thomas and Legallou, Simon and Fest, Thierry and Tarte, Karin and Hinojosa, Robert K. Clarke and Ferrer, Eul{\`a}lia Genesc{\`a} and Ribera, Jos{\'e} Mar{\'i}a and Dey, Aditi and Bailey, Katharine and Fielding, Adele K. and Eissenberg, Linda and Ritchey, Julie and Rettig, Michael and Dipersio, John F. and Kosco-Vilbois, Marie H. and Masternak, Krzysztof and Fischer, Nicolas and Shang, Limin and Ferlin, Walter G.},
URL = {https://univ-rennes.hal.science/hal-02474041},
JOURNAL = {Molecular Cancer Therapeutics},
PUBLISHER = {American Association for Cancer Research},
VOLUME = {17},
NUMBER = {8},
PAGES = {1739-1751},
YEAR = {2018},
MONTH = Aug, DOI = {10.1158/1535-7163.MCT-17-1095},
PDF = {https://univ-rennes.hal.science/hal-02474041/file/Buatois-2018-Preclinical%20Development%20of%20a%20Bispecific%20Antibody.pdf},
HAL_ID = {hal-02474041},
HAL_VERSION = {v1},
}